Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis: Induction Treatment With Mitoxantrone Followed by Long-Term Treatment With Interferon-beta1b
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2011
At a glance
- Drugs Interferon beta-1b; Mitoxantrone
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 21 Jul 2006 New trial record.